CD4 and rheumatoid arthritis: Among CD4+CXCR5+ Tfh cells, the frequency of IL-21-producing cells upon ex vivo stimulation was significantly decreased in early RA patients (p < 0.01) when compared with HCs, while the frequency was intermediate for the RA-risk individuals (Figure 2D).